Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Obviousness
Novartis v. West-Ward – Lead Compound Analysis v. Motivation to Combine
In Novartis Pharm. v. West-Ward Pharm., Appeal no. 2018-1434 (Fed. Cir., May 12, 2019), a three judge panel of Stoll, Plager and Clevenger affirmed the district court’s ruling that the claims of Novartis’ U.S. Pat. No. 8,410,131, directed to using … Continue reading
Posted in Obviousness
Tagged Lead Compound Analysis, Novartis, Obviousness, patent claims, POSA, prior art, West-Ward
Leave a comment
Novartis v. Breckenridge: Obviousness-Type Double Patenting Explained
Without trying to summarize this well-written opinion by Judge Chen, I simply recommend that you store it somewhere and pull it out when you have a tricky obviousness-type double-patenting situation and want a thorough review of the doctrine. The opinion … Continue reading
Posted in Double Patenting, Obviousness
Tagged Abbvie, Breckenridge, Double Patenting, Gilead, Novartis, Obviousness
Leave a comment
Yeda Res. and Dev. v. Mylan – “We don’t need no Stinkin’ Prior Art”
The quote is from “Treasure of the Sierra Madre” when a bandido leader is trying to convince Bogart that his gang are Federales, and Bogie asks to see their badges. In the context of Yeda Res. and Dev. v. Mylan, … Continue reading
Posted in Prior Art
Tagged Federal Circuit, KSR, MPEP, Mylan, Obviousness, PTAB, Warren Woessner, Yeda
Leave a comment
Ex parte Galloway – Two Correlations are Better than One
Although, somehow, examiners and PTAB Judges are supposed to refrain from considering anticipation or obviousness when evaluating claim elements for the “inventive step” required for patent eligibility, that’s just not possible. The claims in Ex parte Galloway were directed to … Continue reading
Posted in Obviousness, PTAB
Tagged Ex Parte Galloway, minichromosome, Obviousness, PSA, PTAB, PTO, s. 101
Leave a comment